MCID: LCT002
MIFTS: 48

Lactose Intolerance

Categories: Gastrointestinal diseases, Genetic diseases, Metabolic diseases

Aliases & Classifications for Lactose Intolerance

MalaCards integrated aliases for Lactose Intolerance:

Name: Lactose Intolerance 12 25 55 6 43 44 15 63 40 73
Lm - Lactose Malabsorption 12
Dairy Product Intolerance 25
Milk Sugar Intolerance 25
Lactose Malabsorption 25
Hypolactasia 25
Alactasia 25

Classifications:



External Ids:

Disease Ontology 12 DOID:10604
ICD10 33 E73 E73.9
MeSH 44 D007787
NCIt 50 C3154
UMLS 73 C0022951

Summaries for Lactose Intolerance

PubMed Health : 63 About lactose intolerance: Stomach ache, bloating, "gas" and diarrhea are all typical digestive symptoms that some people have after eating or drinking dairy products. People who have difficulty digesting dairy products may only tolerate small amounts of lactose (a sugar found in milk and other dairy products). This is called lactose intolerance.But some people who are sensitive to milk might actually have a different problem. It is important to get the diagnosis right before deciding to make major changes to your diet, especially in children, teenagers and people who need more calcium.Lactose intolerance is not an allergy. This is an important difference. People who have a true milk allergy can react to even a tiny amount of dairy foods or milk. But people who are lactose intolerant can sometimes consume quite a lot of these products without having any major problems.

MalaCards based summary : Lactose Intolerance, also known as lm - lactose malabsorption, is related to lactose intolerance, adult type and diarrhea, and has symptoms including nausea and vomiting, constipation and abdominal pain. An important gene associated with Lactose Intolerance is LCT (Lactase), and among its related pathways/superpathways are Metabolism and Glycosaminoglycan metabolism. The drugs Caseins and Chelating Agents have been mentioned in the context of this disorder. Affiliated tissues include testes, small intestine and colon.

Genetics Home Reference : 25 Lactose intolerance is an impaired ability to digest lactose, a sugar found in milk and other dairy products. Lactose is normally broken down by an enzyme called lactase, which is produced by cells in the lining of the small intestine.

MedlinePlus : 43 Lactose intolerance means that you cannot digest foods with lactose in them. Lactose is the sugar found in milk and foods made with milk. After eating foods with lactose in them, you may feel sick to your stomach. You may also have Gas Diarrhea Swelling in your stomach Your doctor may do a blood, breath or stool test to find out if your problems are due to lactose intolerance. Lactose intolerance is not serious. Eating less food with lactose, or using pills or drops to help you digest lactose usually helps. You may need to take a calcium supplement if you don't get enough of it from your diet, since milk and foods made with milk are the most common source of calcium for most people. NIH: National Institute of Diabetes and Digestive and Kidney Diseases

Wikipedia : 76 Lactose intolerance is a condition in which people have symptoms due to the decreased ability to digest... more...

Related Diseases for Lactose Intolerance

Diseases in the Lactose Intolerance family:

Lactose Intolerance, Adult Type

Diseases related to Lactose Intolerance via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 51)
# Related Disease Score Top Affiliating Genes
1 lactose intolerance, adult type 33.6 LCT MCM6
2 diarrhea 31.8 LCT SI SLC5A1
3 osmotic diarrhea 31.6 LCT SLC5A1
4 congenital sucrase-isomaltase deficiency with starch and lactose intolerance 12.4
5 lactase deficiency, congenital 11.6
6 congenital short bowel syndrome 11.2
7 short bowel syndrome 11.2
8 streptococcal group a invasive disease 11.2
9 irritable bowel syndrome 10.6
10 osteoporosis 10.3
11 celiac disease 1 10.2
12 ulcerative colitis 10.2
13 colitis 10.2
14 milk allergy 10.2
15 colorectal cancer 10.1
16 acrodermatitis enteropathica, zinc-deficiency type 10.1
17 inflammatory bowel disease 10.1
18 protein-energy malnutrition 10.1
19 gastroenteritis 10.1
20 acrodermatitis 10.1
21 enteropathica 10.1
22 systemic lupus erythematosus 10.1
23 lupus erythematosus 10.1
24 ichthyosis bullosa of siemens 10.0
25 dumping syndrome 10.0
26 mental depression 10.0
27 depression 10.0
28 nonalcoholic steatohepatitis 10.0
29 arteries, anomalies of 10.0
30 ovarian cancer 10.0
31 prostate cancer 10.0
32 urticaria, aquagenic 10.0
33 enterocolitis 10.0
34 anxiety 10.0
35 beta-thalassemia 10.0
36 coronary artery anomaly 10.0
37 crohn's disease 10.0
38 thalassemia 10.0
39 immunoglobulin alpha deficiency 10.0
40 lymphoma 10.0
41 steatorrhea 10.0
42 giardiasis 10.0
43 dysentery 10.0
44 hyperparathyroidism 10.0
45 urticaria 10.0
46 dyspepsia 10.0
47 dermatitis 10.0
48 thyroiditis 10.0
49 gastrointestinal system disease 10.0
50 measles 10.0

Graphical network of the top 20 diseases related to Lactose Intolerance:



Diseases related to Lactose Intolerance

Symptoms & Phenotypes for Lactose Intolerance

UMLS symptoms related to Lactose Intolerance:


nausea and vomiting, constipation, abdominal pain, diarrhea, icterus, dyspepsia, heartburn, gastrointestinal gas

Drugs & Therapeutics for Lactose Intolerance

Drugs for Lactose Intolerance (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 24)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Caseins Phase 4,Phase 2,Not Applicable
2 Chelating Agents Phase 4,Not Applicable
3 Bifidobacterium Phase 4,Not Applicable
4 Linoleate Phase 1, Phase 2
5
Sorbitol Approved Not Applicable 50-70-4 5780
6
Chromium Approved 7440-47-3 27668
7
Vitamin A Approved, Nutraceutical, Vet_approved Not Applicable 11103-57-4, 68-26-8 445354
8 Retinol palmitate Not Applicable
9 retinol Not Applicable
10 Calcium, Dietary ,Not Applicable
11 Cola ,Not Applicable
12 Sulfalene Not Applicable
13 Antiparasitic Agents Not Applicable
14 Renal Agents Not Applicable
15 Antiprotozoal Agents Not Applicable
16 Anti-Infective Agents Not Applicable
17 Antimalarials Not Applicable
18 Anti-Infective Agents, Urinary Not Applicable
19 Soy Bean Not Applicable
20 Insulin, Globin Zinc Not Applicable
21 insulin Not Applicable
22 alanine Not Applicable
23
Bilirubin Not Applicable 635-65-4 5280352
24 Bone Density Conservation Agents Not Applicable

Interventional clinical trials:

(show all 45)
# Name Status NCT ID Phase Drugs
1 Evaluation of LacTEST for the Diagnosis of Hypolactasia in Adults and Elderly Patients Presenting With Clinical Symptoms of Lactose Intolerance Completed NCT02636413 Phase 4 gaxilose
2 Incidence of Lactose Intolerance Among Self-reported Lactose Intolerant People Completed NCT02878876 Phase 4
3 Effects Comparison of A1 and A2 Milk on Gastrointestinal Physiology, Symptoms and Cognitive Behavior Completed NCT02406469 Phase 4
4 NEOBIFI: Clinical Trial for the Prevention and/or Reduction of the Incidence of Colics in Infants Completed NCT03219931 Phase 4 Bifidobacterium breve BR03 and Bifidobacterium breve B632;Placebos
5 Effects of Mesalamine and Amitriptyline on Irritable Bowel Syndrome Withdrawn NCT02190526 Phase 4 Mesalazine(asacol 800 mg);Amitriptyline;placebo like asacol;placebo like amitriptyline
6 Efficacy, Safety, and Tolerability Study of RP-G28 in Subjects With Lactose Intolerance Completed NCT02673749 Phase 2, Phase 3 RP-G28
7 A Non-inferiority, Multicenter and Randomized, Multiple-Dose Study About a Treatment to Hypolactasia Completed NCT01145586 Phase 3 Lactase Oral Tablets
8 A Non-inferiority, Multicenter and Randomized, Single-Dose Study About a Treatment to Hypolactasia (LAILAI) Completed NCT01145339 Phase 3 Lactase
9 Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance Recruiting NCT03597516 Phase 3 RP-G28;Placebos
10 Evaluation of the Efficacy of a New Infant Formula in Subjects With Cow's Milk Allergy Unknown status NCT02149134 Phase 2
11 Effectiveness, Safety and Tolerability Study of RP-G28 for Symptoms Associated With Lactose Intolerance Completed NCT01113619 Phase 2 RP-G28 or placebo;RP-G28 or placebo
12 Cheese Intake,CLA and Hypercholesterolemia Completed NCT01561846 Phase 1, Phase 2
13 Effect of a Standard Meal on the Pharmacokinetic Profile of RP-G28 in Healthy Adult Male and Female Subjects Completed NCT03563846 Phase 1 RP-G28
14 The Effects of Lactose Intolerance on Gastrointestinal Function and Symptoms in a Chinese Population Unknown status NCT01286597 Not Applicable
15 Whole Milk Intake and Cardio-metabolic Risk Factors Unknown status NCT02798718 Not Applicable
16 Perceived Lactose Intolerance Completed NCT01331265
17 Comparison of the Colonic Metabolism in Patients With Lactose Intolerance and Healthy Controls Completed NCT02171403
18 Secondary Lactose Intolerance Due to Chronic Norovirus Infection Completed NCT01840891 Not Applicable
19 The Effect of Probiotics on Lactose Intolerance Completed NCT01593800 Not Applicable
20 β-galactosidase Producing Probiotic Strains to Improve Lactose Digestion Completed NCT02518295 Not Applicable
21 Amount of Lactose Causing Symptoms in People With Lactose Intolerance and Ulcerative Colitis Completed NCT00403923
22 Effects of Raw Versus Other Milk Sources on Lactose Digestion Completed NCT01129791 Not Applicable
23 Amount of Lactose Causing Symptoms in Lactose Intolerant People Completed NCT00395954
24 Modulation of Lactase Expression by a New PPARgamma Ligand in Duodenal Biopsies Completed NCT02902016 Not Applicable GED
25 Althera® Versus Nutramigen / Cow's Milk Intolerance Completed NCT01727115 Not Applicable
26 Acid Lactase in Combination With Yoghurt Bacteria for Improvement of Lactose Digestion in Lactose Malabsorbers Completed NCT01593631 Not Applicable
27 HYBRID: Hydrogen Breath Test in Lactose Digestion Completed NCT02703987 Not Applicable
28 Effects of Lactose on Fecal Microflora Completed NCT00599859 Not Applicable
29 Calcium Absorption in Postmenopausal Thai Women Completed NCT02291315
30 Colonization and Persistence of Bifidobacterium Longum Completed NCT01650753 Not Applicable
31 Endomicroscopy, IBS and Food Intolerance Completed NCT01692613
32 Effect of Fructose on Colonic Microflora Completed NCT00775567 Not Applicable
33 Post-exercise Recovery After Dietary Protein Ingestion in Healthy Young Men (Meat-Milk Study) Completed NCT01578590 Not Applicable
34 Observational Study With PASCALLERG ® in Patients With Hay Fever Completed NCT01660737
35 "Functional Bowel Disorder. Investigation in General Practice" Completed NCT01153295 Not Applicable
36 Improving Bone Health in Adolescence Through Targeted Behavioral Intervention Completed NCT02202889 Not Applicable
37 Lactose Intolerance and Cow's Milk Protein Allergy in Non-celiac Wheat Sensitivity Patients Recruiting NCT03008252
38 Fructose and Lactose Intolerance and Malabsorption in Functional Gastrointestinal Disorders Recruiting NCT02085889
39 Effect of Probiotic Supplementation on Lactose Maldigestion Induced by Lactose Solution Recruiting NCT03814668 Not Applicable
40 Comparing the Digestion of Milk With Different Beta-casein Protein Content by Dairy Intolerant Persons Recruiting NCT03713346 Not Applicable
41 Effects of A2 Milk on Gastrointestinal Function in Non-lactose Milk Intolerance Active, not recruiting NCT03060395 Not Applicable
42 Clinical Utility of Breath Tests in GI Not yet recruiting NCT03261856
43 Validation of a Home-Screening Test for Lactose Intolerance Suspended NCT00844766
44 Prevalence of Lactose Intolerance Following Stem Cell Transplantation Terminated NCT00247806
45 Evaluation of Fecal Calprotectin Screening and a Gastroenterology Questionnaire for Triaging Children With Chronic Abdominal Pain and/or Diarrhea Referred to a Pediatric Gastroenterology Service Terminated NCT01866774 Not Applicable

Search NIH Clinical Center for Lactose Intolerance

Cochrane evidence based reviews: lactose intolerance

Genetic Tests for Lactose Intolerance

Anatomical Context for Lactose Intolerance

MalaCards organs/tissues related to Lactose Intolerance:

41
Testes, Small Intestine, Colon, Kidney, Bone, Liver, Thyroid

Publications for Lactose Intolerance

Articles related to Lactose Intolerance:

(show top 50) (show all 456)
# Title Authors Year
1
One-third of children with lactose intolerance managed to achieve a regular diet at the three-year follow-up point. ( 29505134 )
2018
2
Prevalence, cause and diagnosis of lactose intolerance in children aged 1-5 years: a systematic review of 1995-2015 literature. ( 29222879 )
2018
3
Managing acute pain in patients who report lactose intolerance: the safety of an old excipient re-examined. ( 29796247 )
2018
4
The effects of probiotics in lactose intolerance: A systematic review. ( 29425071 )
2018
5
An Electronic Questionnaire Survey Evaluating the Perceived Prevalence and Practices of Lactose Intolerance in 1 to 5 Year Old Children in South East Asia. ( 29992116 )
2018
6
Caries in children with lactose intolerance and cow's milk protein allergy. ( 30231171 )
2018
7
Prebiotics for Lactose Intolerance: Variability in Galacto-Oligosaccharide Utilization by Intestinal Lactobacillus rhamnosus. ( 30332787 )
2018
8
Analysis of lactase in lactose intolerance supplements. ( 30462373 )
2018
9
Gender, Age, Race and Lactose Intolerance: Is There Evidence to Support a Differential Symptom Response? A Scoping Review. ( 30544891 )
2018
10
Lactose Intolerance (LCT-13910C>T) Genotype Is Associated with Plasma 25-Hydroxyvitamin D Concentrations in Caucasians: A Mendelian Randomization Study. ( 28446633 )
2017
11
Genetic predictors of celiac disease, lactose intolerance, and vitamin D function and presence of peptide morphins in urine of children with neurodevelopmental disorders. ( 28738753 )
2017
12
Lactase Non-persistence and Lactose Intolerance. ( 28421381 )
2017
13
Lactose intolerance and gastrointestinal cow's milk allergy in infants and children - common misconceptions revisited. ( 29270244 )
2017
14
Prevalence of lactose intolerance in patients with diarrhea-predominant irritable bowel syndrome: data from a tertiary center in southern China. ( 29157302 )
2017
15
Successful Treatment With Phenobarbital Following Lactase Supplementation in an Infant With Lactose Intolerance. ( 28821216 )
2017
16
Diagnosis of genetic predisposition for lactose intolerance by high resolution melting analysis. ( 28132945 )
2017
17
Comparison of an increased waist circumference with a positive hydrogen breath test as a clinical predictor of lactose intolerance. ( 28318180 )
2017
18
Lactose Intolerance and Colorectal Cancer. ( 29159160 )
2017
19
ORAL ADMINISTRATION OF EXOGENOUS LACTASE IN TABLETS FOR PATIENTS DIAGNOSED WITH LACTOSE INTOLERANCE DUE TO PRIMARY HYPOLACTASIA. ( 27706451 )
2016
20
Perception of lactose intolerance impairs health-related quality of life. ( 27188918 )
2016
21
Prevalence and Symptom Correlation of Lactose Intolerance in the North East Part of Bangladesh. ( 26931253 )
2016
22
The incidence of infants with rotavirus enteritis combined with lactose intolerance. ( 27005498 )
2016
23
A relationship between vitamin D, parathyroid hormone, calcium levels and lactose intolerance in type 2 diabetic patients and healthy subjects: Vitamin D in type 2 diabetic patients. ( 27642086 )
2016
24
Differentiating milk allergy (IgE and non-IgE mediated) from lactose intolerance: understanding the underlying mechanisms and presentations. ( 27481986 )
2016
25
Diagnosis of lactose intolerance. ( 28038856 )
2016
26
Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine. ( 27577569 )
2016
27
Lactase persistence versus lactose intolerance: Is there an intermediate phenotype? ( 26601570 )
2016
28
The effects of the DDS-1 strain of lactobacillus on symptomatic relief for lactose intolerance - a randomized, double-blind, placebo-controlled, crossover clinical trial. ( 27207411 )
2016
29
Clinical evaluation, biochemistry and genetic polymorphism analysis for the diagnosis of lactose intolerance in a population from northeastern Brazil. ( 26934237 )
2016
30
Do patients with lactose intolerance exhibit more frequent comorbidities than patients without lactose intolerance? An analysis of routine data from German medical practices. ( 27065730 )
2016
31
Erratum to: the effects of the DDS-1 strain of lactobacillus on symptomatic relief for lactose intolerance - a randomized, double-blind, placebo-controlled, crossover clinical trial. ( 27716234 )
2016
32
Lactose Intolerance and Symptom Pattern of Lactose Intolerance among Healthy Volunteers. ( 29201715 )
2016
33
The management of lactose intolerance among primary care physicians and its correlation with management by gastroenterologists: the SEPD-SEMG national survey. ( 26334462 )
2015
34
Lactose intolerance in Indonesian children. ( 26715082 )
2015
35
Congenital lactose intolerance is triggered by severe mutations on both alleles of the lactase gene. ( 25881162 )
2015
36
Lactose intolerance. ( 26715083 )
2015
37
Self-reported lactose intolerance in clinic patients with functional gastrointestinal symptoms: prevalence, risk factors, and impact on food choices. ( 26095206 )
2015
38
Lactose Intolerance in Adults: Biological Mechanism and Dietary Management. ( 26393648 )
2015
39
P543. Assessment of lactose intolerance in ulcerative colitis patients on remission. ( 25718041 )
2015
40
Recent Advances on Lactose Intolerance: Tolerance Thresholds and Currently Available Solutions. ( 26713460 )
2015
41
Prevalence of Lactose Malabsorption and Lactose Intolerance in Pediatric Patients with Selected Gastrointestinal Diseases. ( 26768639 )
2015
42
Contribution of Colonic Fermentation and Fecal Water Toxicity to the Pathophysiology of Lactose-Intolerance. ( 26371036 )
2015
43
The Diverse Forms of Lactose Intolerance and the Putative Linkage to Several Cancers. ( 26343715 )
2015
44
Probiotics for lactose intolerance and irritable bowel syndrome. ( 26087202 )
2015
45
The management of lactose intolerance among primary care physicians and its correlation with management by gastroenterologists: The SEPD-SEMG national survey. ( 26198877 )
2015
46
The Interrelationships between Lactose Intolerance and the Modern Dairy Industry: Global Perspectives in Evolutional and Historical Backgrounds. ( 26404364 )
2015
47
Effect of raw milk on lactose intolerance: a randomized controlled pilot study. ( 24615309 )
2014
48
An association between lactose intolerance and anthropometric variables in the Sudanese Shagia tribe (East Africa). ( 24502673 )
2014
49
Lactose intolerance genetic testing: Is it useful as routine screening? Results on 1426 south-central Italy patients. ( 25281930 )
2014
50
Lactose intolerance and risk of lung, breast and ovarian cancers: aetiological clues from a population-based study in Sweden. ( 25314053 )
2014

Variations for Lactose Intolerance

ClinVar genetic disease variations for Lactose Intolerance:

6 (show top 50) (show all 122)
# Gene Variation Type Significance SNP ID Assembly Location
1 LCT NM_002299.3(LCT): c.54G> C (p.Trp18Cys) single nucleotide variant Uncertain significance rs886054870 GRCh37 Chromosome 2, 136594686: 136594686
2 LCT NM_002299.3(LCT): c.54G> C (p.Trp18Cys) single nucleotide variant Uncertain significance rs886054870 GRCh38 Chromosome 2, 135837116: 135837116
3 LCT NM_002299.3(LCT): c.729C> G (p.Val243=) single nucleotide variant Likely benign rs3816088 GRCh37 Chromosome 2, 136587238: 136587238
4 LCT NM_002299.3(LCT): c.729C> G (p.Val243=) single nucleotide variant Likely benign rs3816088 GRCh38 Chromosome 2, 135829668: 135829668
5 LCT NM_002299.3(LCT): c.2457C> T (p.His819=) single nucleotide variant Uncertain significance rs149425549 GRCh37 Chromosome 2, 136567460: 136567460
6 LCT NM_002299.3(LCT): c.2457C> T (p.His819=) single nucleotide variant Uncertain significance rs149425549 GRCh38 Chromosome 2, 135809890: 135809890
7 LCT NM_002299.3(LCT): c.2760C> T (p.Gly920=) single nucleotide variant Uncertain significance rs200579267 GRCh37 Chromosome 2, 136567157: 136567157
8 LCT NM_002299.3(LCT): c.2760C> T (p.Gly920=) single nucleotide variant Uncertain significance rs200579267 GRCh38 Chromosome 2, 135809587: 135809587
9 LCT NM_002299.3(LCT): c.3390G> A (p.Glu1130=) single nucleotide variant Uncertain significance rs886054865 GRCh37 Chromosome 2, 136566527: 136566527
10 LCT NM_002299.3(LCT): c.3390G> A (p.Glu1130=) single nucleotide variant Uncertain significance rs886054865 GRCh38 Chromosome 2, 135808957: 135808957
11 LCT NM_002299.3(LCT): c.3532C> T (p.Leu1178=) single nucleotide variant Uncertain significance rs886054864 GRCh37 Chromosome 2, 136566385: 136566385
12 LCT NM_002299.3(LCT): c.3532C> T (p.Leu1178=) single nucleotide variant Uncertain significance rs886054864 GRCh38 Chromosome 2, 135808815: 135808815
13 LCT NM_002299.3(LCT): c.3595G> A (p.Ala1199Thr) single nucleotide variant Uncertain significance rs886054863 GRCh37 Chromosome 2, 136566322: 136566322
14 LCT NM_002299.3(LCT): c.3595G> A (p.Ala1199Thr) single nucleotide variant Uncertain significance rs886054863 GRCh38 Chromosome 2, 135808752: 135808752
15 LCT NM_002299.3(LCT): c.3986C> T (p.Thr1329Met) single nucleotide variant Uncertain significance rs555708380 GRCh37 Chromosome 2, 136564885: 136564885
16 LCT NM_002299.3(LCT): c.3986C> T (p.Thr1329Met) single nucleotide variant Uncertain significance rs555708380 GRCh38 Chromosome 2, 135807315: 135807315
17 LCT NM_002299.3(LCT): c.4239A> G (p.Pro1413=) single nucleotide variant Uncertain significance rs752925060 GRCh37 Chromosome 2, 136562562: 136562562
18 LCT NM_002299.3(LCT): c.4239A> G (p.Pro1413=) single nucleotide variant Uncertain significance rs752925060 GRCh38 Chromosome 2, 135804992: 135804992
19 LCT NM_002299.3(LCT): c.5493C> T (p.Tyr1831=) single nucleotide variant Uncertain significance rs369410973 GRCh37 Chromosome 2, 136547211: 136547211
20 LCT NM_002299.3(LCT): c.5493C> T (p.Tyr1831=) single nucleotide variant Uncertain significance rs369410973 GRCh38 Chromosome 2, 135789641: 135789641
21 LCT NM_002299.3(LCT): c.5656G> A (p.Val1886Ile) single nucleotide variant Uncertain significance rs376732886 GRCh37 Chromosome 2, 136546022: 136546022
22 LCT NM_002299.3(LCT): c.5656G> A (p.Val1886Ile) single nucleotide variant Uncertain significance rs376732886 GRCh38 Chromosome 2, 135788452: 135788452
23 LCT NM_002299.3(LCT): c.5771T> C (p.Val1924Ala) single nucleotide variant Uncertain significance rs886054861 GRCh37 Chromosome 2, 136545907: 136545907
24 LCT NM_002299.3(LCT): c.5771T> C (p.Val1924Ala) single nucleotide variant Uncertain significance rs886054861 GRCh38 Chromosome 2, 135788337: 135788337
25 LCT NM_002299.3(LCT): c.*10A> C single nucleotide variant Uncertain significance rs200994158 GRCh37 Chromosome 2, 136545884: 136545884
26 LCT NM_002299.3(LCT): c.*10A> C single nucleotide variant Uncertain significance rs200994158 GRCh38 Chromosome 2, 135788314: 135788314
27 LCT NM_002299.3(LCT): c.*251G> A single nucleotide variant Uncertain significance rs886054860 GRCh37 Chromosome 2, 136545643: 136545643
28 LCT NM_002299.3(LCT): c.*251G> A single nucleotide variant Uncertain significance rs886054860 GRCh38 Chromosome 2, 135788073: 135788073
29 LCT NM_002299.3(LCT): c.318C> T (p.Asp106=) single nucleotide variant Likely benign rs34307240 GRCh37 Chromosome 2, 136594422: 136594422
30 LCT NM_002299.3(LCT): c.318C> T (p.Asp106=) single nucleotide variant Likely benign rs34307240 GRCh38 Chromosome 2, 135836852: 135836852
31 LCT NM_002299.3(LCT): c.319G> A (p.Glu107Lys) single nucleotide variant Uncertain significance rs761296720 GRCh37 Chromosome 2, 136594421: 136594421
32 LCT NM_002299.3(LCT): c.319G> A (p.Glu107Lys) single nucleotide variant Uncertain significance rs761296720 GRCh38 Chromosome 2, 135836851: 135836851
33 LCT NM_002299.3(LCT): c.454G> A (p.Ala152Thr) single nucleotide variant Likely benign rs114525655 GRCh37 Chromosome 2, 136594286: 136594286
34 LCT NM_002299.3(LCT): c.454G> A (p.Ala152Thr) single nucleotide variant Likely benign rs114525655 GRCh38 Chromosome 2, 135836716: 135836716
35 LCT NM_002299.3(LCT): c.1419C> A (p.Gly473=) single nucleotide variant Benign rs6719488 GRCh37 Chromosome 2, 136575199: 136575199
36 LCT NM_002299.3(LCT): c.1419C> A (p.Gly473=) single nucleotide variant Benign rs6719488 GRCh38 Chromosome 2, 135817629: 135817629
37 LCT NM_002299.3(LCT): c.1650C> G (p.Gly550=) single nucleotide variant Likely benign rs35093754 GRCh37 Chromosome 2, 136574968: 136574968
38 LCT NM_002299.3(LCT): c.1650C> G (p.Gly550=) single nucleotide variant Likely benign rs35093754 GRCh38 Chromosome 2, 135817398: 135817398
39 LCT NM_002299.3(LCT): c.1780C> G (p.Gln594Glu) single nucleotide variant Uncertain significance rs886054867 GRCh37 Chromosome 2, 136570454: 136570454
40 LCT NM_002299.3(LCT): c.1780C> G (p.Gln594Glu) single nucleotide variant Uncertain significance rs886054867 GRCh38 Chromosome 2, 135812884: 135812884
41 LCT NM_002299.3(LCT): c.3341A> G (p.Gln1114Arg) single nucleotide variant Uncertain significance rs148838160 GRCh37 Chromosome 2, 136566576: 136566576
42 LCT NM_002299.3(LCT): c.3341A> G (p.Gln1114Arg) single nucleotide variant Uncertain significance rs148838160 GRCh38 Chromosome 2, 135809006: 135809006
43 LCT NM_002299.3(LCT): c.3599C> T (p.Thr1200Met) single nucleotide variant Uncertain significance rs148317168 GRCh37 Chromosome 2, 136566318: 136566318
44 LCT NM_002299.3(LCT): c.3599C> T (p.Thr1200Met) single nucleotide variant Uncertain significance rs148317168 GRCh38 Chromosome 2, 135808748: 135808748
45 LCT NM_002299.3(LCT): c.3759G> A (p.Thr1253=) single nucleotide variant Uncertain significance rs764860323 GRCh37 Chromosome 2, 136566158: 136566158
46 LCT NM_002299.3(LCT): c.3759G> A (p.Thr1253=) single nucleotide variant Uncertain significance rs764860323 GRCh38 Chromosome 2, 135808588: 135808588
47 LCT NM_002299.3(LCT): c.4026G> A (p.Thr1342=) single nucleotide variant Uncertain significance rs150640616 GRCh37 Chromosome 2, 136564845: 136564845
48 LCT NM_002299.3(LCT): c.4026G> A (p.Thr1342=) single nucleotide variant Uncertain significance rs150640616 GRCh38 Chromosome 2, 135807275: 135807275
49 LCT NM_002299.3(LCT): c.4122C> T (p.Tyr1374=) single nucleotide variant Uncertain significance rs557321611 GRCh37 Chromosome 2, 136564749: 136564749
50 LCT NM_002299.3(LCT): c.4122C> T (p.Tyr1374=) single nucleotide variant Uncertain significance rs557321611 GRCh38 Chromosome 2, 135807179: 135807179

Expression for Lactose Intolerance

Search GEO for disease gene expression data for Lactose Intolerance.

Pathways for Lactose Intolerance

GO Terms for Lactose Intolerance

Cellular components related to Lactose Intolerance according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular exosome GO:0070062 9.02 ALDOB ANPEP SI SLC5A1 TREH

Biological processes related to Lactose Intolerance according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 metabolic process GO:0008152 9.13 LCT SI TREH
2 polysaccharide digestion GO:0044245 8.62 LCT SI

Molecular functions related to Lactose Intolerance according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 hydrolase activity GO:0016787 9.55 ANPEP LCT MCM6 SI TREH
2 hydrolase activity, hydrolyzing O-glycosyl compounds GO:0004553 8.96 LCT SI
3 hydrolase activity, acting on glycosyl bonds GO:0016798 8.8 LCT SI TREH

Sources for Lactose Intolerance

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....